Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRNP40 pseudogene 1 (SNRNP40P1) is an uncharacterized pseudogene that derives from the SNRNP40 gene sequence, which encodes a protein component of the U5 small nuclear ribonucleoprotein (snRNP) involved in splicing pre-mRNA as part of the spliceosome[1]. Unlike its parent gene, SNRNP40P1 is not protein-coding and has no documented molecular function, disease relevance, or established synonyms. No direct biological, pharmacological, or clinical information is available for SNRNP40P1 as of current genomic databases and literature, and it does not qualify as a therapeutic target or biomarker. The entity may represent an annotation artifact, uncharacterized pseudogene, or a mistaken/lost entry in gene nomenclature. If you intended a different spelling or a functional gene related to snRNPs, consider verifying the gene name. Most pseudogenes do not have established roles or aliases unless aberrant expression is established in cancer or other disease contexts (as in SNRPFP1 [SNRPF pseudogene 1][3]), but there is no such evidence for SNRNP40P1.
Not applicable; there are no drugs or therapeutic agents known to interact with this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SNRNP40 pseudogene 1 (SNRNP40P1).